Clinical Trial Update: UVA1 Light for Treatment of Scleroderma and Similar Conditions [NA]

View source ↗

Summary

Completed clinical trial evaluating UVA1 light therapy for systemic sclerosis (scleroderma) and keloids.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keloids
• Systemic Sclerosis

Snippet

Sponsor: University of Michigan | Conditions: Scleroderma, Keloids | NA | Status: COMPLETED